Interestingly, CD47 expression correlates with both CD44 expression and EMT, suggesting CD47 as a promoter of cancer cell stemness, tumor spreading, and resistance to PD-1/PDL-1 inhibitors [203]. Here, CD47 is linked to neoplasm.